The emerging practice of vaping 5meo dimethyltryptamine in Canada presents serious hazards and challenging legal issues. Currently, 5meo copyright remains a Schedule One substance within this CDSA, causing its possession and sale prohibited. While ingestion delivers the compound quickly, it furthermore presents new physical dangers connected with v